Resources

Do younger diabetics have the same prevalence of peripheral neuropathy as older patients?… 

New research assesses safety and efficacy of linagliptin as add on treatment in elderly diabetes patients….

Metformin may have a new partner…. 

Intensive blood sugar goal may not be the answer…. 

New dietary considerations for type 2 diabetes….

Does Bydureon once weekly show benefit in type 2 diabetic patients?…

How early is too early?

David Joffe, BSPharm, CDE, Editor-in-chief, Diabetes In Control In 2003, the Treat to Target Trial study results were published. The study compared the effectiveness of a patient mediated titration schedule with both NPH and glargine, and also whether patient titration was as good as a prescriber-based titration….

  This week, we have an update for you on Dr. Stanley Schwartz’s slides series on the state of diabetes in the U.S. This set covers topics including: a brief overview of the "Natural History of Diabetes," the "Ominous Octet," and "Why Bother to Treat Aggressively."…

Ramsi Ajjan Richard, a 20-year-old man, is referred to the diabetes clinic with newly diagnosed diabetes (fasting glucose on two occasions more than 10 mmol/L. He has had osmotic symptons (polyuria and polydipsia) for at least 6 months and his weight has recently increased by about 14 kg….